CA Stock MarketDetailed Quotes

BriaCell Therapeutics Corp (BCT)

Watchlist
  • 6.010
  • -0.160-2.59%
15min DelayTrading Jan 23 11:05 ET
37.33MMarket Cap-0.13P/E (TTM)

BriaCell Therapeutics Corp (BCT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Oct 31, 2025
(FY)Jul 31, 2025
(Q4)Jul 31, 2025
(Q3)Apr 30, 2025
(Q2)Jan 31, 2025
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
61.52%8.32M
-18.38%27.2M
48.31%8.55M
-31.44%6.33M
-27.06%7.17M
-39.40%5.15M
43.22%33.33M
-25.15%5.77M
62.58%9.23M
119.10%9.83M
Selling and administrative expenses
10.21%1.64M
-3.55%5.93M
5.98%1.44M
-3.43%1.52M
-5.56%1.48M
-9.62%1.49M
-22.47%6.15M
-46.32%1.36M
-13.46%1.57M
9.70%1.57M
-General and administrative expense
10.21%1.64M
-3.55%5.93M
5.98%1.44M
-3.43%1.52M
-5.56%1.48M
-9.62%1.49M
-22.47%6.15M
-46.32%1.36M
-13.46%1.57M
9.70%1.57M
Research and development costs
82.35%6.68M
-21.74%21.27M
61.40%7.11M
-37.18%4.81M
-31.16%5.68M
-46.55%3.67M
77.21%27.18M
-14.75%4.41M
98.36%7.66M
170.44%8.26M
Operating profit
-61.52%-8.32M
18.38%-27.2M
-48.31%-8.55M
31.44%-6.33M
27.06%-7.17M
39.40%-5.15M
-43.22%-33.33M
25.15%-5.77M
-62.58%-9.23M
-119.10%-9.83M
Net non-operating interest income (expenses)
271.51%48.48K
-71.19%82.98K
1,672,100.00%33.44K
-166.30%-10.35K
-42.60%46.83K
-93.16%13.05K
-67.68%288.02K
-100.00%2
-93.84%15.61K
-66.09%81.6K
Non-operating interest income
271.51%48.48K
-58.35%119.96K
1,672,100.00%33.44K
70.65%26.63K
-42.60%46.83K
-93.16%13.05K
-67.68%288.02K
-100.00%2
-93.84%15.61K
-66.09%81.6K
Non-operating interest expense
----
--36.98K
--0
--36.98K
----
----
--0
--0
--0
----
Other net income (expenses)
99.44%-3.87K
-97.99%565.68K
-92.11%356.72K
-98.96%113.67K
149.48%784.78K
-104.83%-689.49K
1,252.34%28.11M
-11.01%4.52M
1,965.18%10.91M
79.23%-1.59M
Gain on sale of security
106.63%40.96K
-97.20%789.9K
-91.16%404.1K
-98.39%176.41K
152.78%827.37K
-104.33%-617.98K
1,257.46%28.22M
-10.00%4.57M
1,972.18%10.94M
79.47%-1.57M
Income before tax
-42.01%-8.28M
-438.50%-26.56M
-553.78%-8.16M
-467.85%-6.22M
44.08%-6.34M
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
Income tax
Earnings from equity interest net of tax
Net income
-42.01%-8.28M
-438.50%-26.56M
-553.78%-8.16M
-467.85%-6.22M
44.08%-6.34M
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
Net income continuous operations
-42.01%-8.28M
-438.50%-26.56M
-553.78%-8.16M
-467.85%-6.22M
44.08%-6.34M
-197.83%-5.83M
75.71%-4.93M
48.37%-1.25M
134.57%1.69M
4.61%-11.33M
Noncontrolling interests
-198.01%-80.76K
-74.38%-244.27K
-110.30%-72.74K
-316.83%-98.03K
-18.07%-46.41K
36.49%-27.1K
-140.08K
-34.59K
-23.52K
-39.31K
Net income attributable to the company
-41.28%-8.2M
-449.14%-26.31M
-566.41%-8.09M
-457.10%-6.13M
44.30%-6.29M
-196.68%-5.8M
76.40%-4.79M
49.80%-1.21M
135.05%1.72M
4.94%-11.29M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-41.28%-8.2M
-449.14%-26.31M
-566.41%-8.09M
-457.10%-6.13M
44.30%-6.29M
-196.68%-5.8M
76.40%-4.79M
49.80%-1.21M
135.05%1.72M
4.94%-11.29M
Diluted earnings per share
86.69%-4.35
-42.38%-62.19
57.39%-4.295
-201.86%-16.4
78.10%-23.3
-157.32%-32.67
77.60%-43.68
55.20%-10.08
133.54%16.1
7.88%-106.4
Basic earnings per share
86.69%-4.35
-42.38%-62.19
57.39%-4.295
-201.86%-16.4
78.10%-23.3
56.44%-32.67
77.60%-43.68
55.20%-10.08
133.54%16.1
7.88%-106.4
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Oct 31, 2025(FY)Jul 31, 2025(Q4)Jul 31, 2025(Q3)Apr 30, 2025(Q2)Jan 31, 2025(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024(Q2)Jan 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 61.52%8.32M-18.38%27.2M48.31%8.55M-31.44%6.33M-27.06%7.17M-39.40%5.15M43.22%33.33M-25.15%5.77M62.58%9.23M119.10%9.83M
Selling and administrative expenses 10.21%1.64M-3.55%5.93M5.98%1.44M-3.43%1.52M-5.56%1.48M-9.62%1.49M-22.47%6.15M-46.32%1.36M-13.46%1.57M9.70%1.57M
-General and administrative expense 10.21%1.64M-3.55%5.93M5.98%1.44M-3.43%1.52M-5.56%1.48M-9.62%1.49M-22.47%6.15M-46.32%1.36M-13.46%1.57M9.70%1.57M
Research and development costs 82.35%6.68M-21.74%21.27M61.40%7.11M-37.18%4.81M-31.16%5.68M-46.55%3.67M77.21%27.18M-14.75%4.41M98.36%7.66M170.44%8.26M
Operating profit -61.52%-8.32M18.38%-27.2M-48.31%-8.55M31.44%-6.33M27.06%-7.17M39.40%-5.15M-43.22%-33.33M25.15%-5.77M-62.58%-9.23M-119.10%-9.83M
Net non-operating interest income (expenses) 271.51%48.48K-71.19%82.98K1,672,100.00%33.44K-166.30%-10.35K-42.60%46.83K-93.16%13.05K-67.68%288.02K-100.00%2-93.84%15.61K-66.09%81.6K
Non-operating interest income 271.51%48.48K-58.35%119.96K1,672,100.00%33.44K70.65%26.63K-42.60%46.83K-93.16%13.05K-67.68%288.02K-100.00%2-93.84%15.61K-66.09%81.6K
Non-operating interest expense ------36.98K--0--36.98K----------0--0--0----
Other net income (expenses) 99.44%-3.87K-97.99%565.68K-92.11%356.72K-98.96%113.67K149.48%784.78K-104.83%-689.49K1,252.34%28.11M-11.01%4.52M1,965.18%10.91M79.23%-1.59M
Gain on sale of security 106.63%40.96K-97.20%789.9K-91.16%404.1K-98.39%176.41K152.78%827.37K-104.33%-617.98K1,257.46%28.22M-10.00%4.57M1,972.18%10.94M79.47%-1.57M
Income before tax -42.01%-8.28M-438.50%-26.56M-553.78%-8.16M-467.85%-6.22M44.08%-6.34M-197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M4.61%-11.33M
Income tax
Earnings from equity interest net of tax
Net income -42.01%-8.28M-438.50%-26.56M-553.78%-8.16M-467.85%-6.22M44.08%-6.34M-197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M4.61%-11.33M
Net income continuous operations -42.01%-8.28M-438.50%-26.56M-553.78%-8.16M-467.85%-6.22M44.08%-6.34M-197.83%-5.83M75.71%-4.93M48.37%-1.25M134.57%1.69M4.61%-11.33M
Noncontrolling interests -198.01%-80.76K-74.38%-244.27K-110.30%-72.74K-316.83%-98.03K-18.07%-46.41K36.49%-27.1K-140.08K-34.59K-23.52K-39.31K
Net income attributable to the company -41.28%-8.2M-449.14%-26.31M-566.41%-8.09M-457.10%-6.13M44.30%-6.29M-196.68%-5.8M76.40%-4.79M49.80%-1.21M135.05%1.72M4.94%-11.29M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -41.28%-8.2M-449.14%-26.31M-566.41%-8.09M-457.10%-6.13M44.30%-6.29M-196.68%-5.8M76.40%-4.79M49.80%-1.21M135.05%1.72M4.94%-11.29M
Diluted earnings per share 86.69%-4.35-42.38%-62.1957.39%-4.295-201.86%-16.478.10%-23.3-157.32%-32.6777.60%-43.6855.20%-10.08133.54%16.17.88%-106.4
Basic earnings per share 86.69%-4.35-42.38%-62.1957.39%-4.295-201.86%-16.478.10%-23.356.44%-32.6777.60%-43.6855.20%-10.08133.54%16.17.88%-106.4
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Tariff game between the US and Europe shakes the market! Will TACO happen again?
Amidst the global market turbulence triggered by the US-Europe dispute over Greenland, a single post by Trump instantly reversed market tren Show More